Delivery Order SPE2DB22D2005-SPE2DB26FJEJ0
- Not listed
- The Defense Logistics Agency awarded a $6,007.38 delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This firm fixed-price contract, with an ultimate completion date of July 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $16,124.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $9,591.59 on September 26, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed price, non-set-aside delivery order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,525.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injections on July 24, 2025. This firm fixed-price, competitively awarded contract is classified as a delivery order with no set-aside designation and carries an ultimate completion date of July 25, 2025. The pharmaceutical product will be performed from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $16,835.69 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors, with a completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply arrangement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 15 mg/0.5 ml pen injectors with a ceiling value of $20,970.99. This is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $3,431.61 on August 21, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's larger relationship...
- The Defense Logistics Agency awarded a delivery order valued at $18,066.92 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The product will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections, valued at $5,504.59. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 28, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJEJ0Delivery Order
The Defense Logistics Agency awarded a $1,522.24 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. This award is issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 and extending through December 2026, which serves as a global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio with the Defense Logistics Agency and its Medical Supply Chain, delivering diverse therapeutic products including specialty medications, vaccines, and medical devices to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/22/25 |